Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 8—August 2020
Dispatch

Leishmania infantum in US-Born Dog

Marcos E. de AlmeidaComments to Author , Dennis R. Spann, and Richard S. Bradbury
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.E. de Almeida, R.S. Bradbury); Sacramento Area Veterinary Internal Medicine, Sacramento, California, USA (D.R. Spann)

Cite This Article

Abstract

Leishmaniasis is a vectorborne disease that can infect humans, dogs, and other mammals. We identified one of its causative agents, Leishmania infantum, in a dog born in California, USA, demonstrating potential for autochthonous infections in this country. Our finding bolsters the need for improved leishmaniasis screening practices in the United States.

Leishmaniasis is a tropical and subtropical zoonosis affecting 0.9–1.6 million persons every year. Its manifestations range from self-healing cutaneous lesions to severe visceral leishmaniasis (VL) forms that can be fatal (1,2). In the Americas, VL is usually caused by Leishmania infantum parasites, which several species of blood-feeding sand fly vectors can transmit to humans and other reservoirs. In urban areas, dogs are the main domestic reservoirs of L. infantum, maintaining the parasitic life cycle and facilitating transmission of parasites to humans and other mammals (3). Alternative routes of Leishmania spp. transmission, such as vertical transmission and dog-to-dog transmission by biting, have been associated with autochthonous canine leishmaniasis (Can-VL) (24). In addition, biochemical abnormalities, such as genetic mutations of macrophage proteins, have been associated with increased susceptibility to VL in some breeds, including boxers (5).

The accurate differentiation between clinical and subclinical infections is critical in determining the appropriate course of treatment. However, correct diagnosis of Can-VL is challenging because an absence of amastigotes in samples, including blood and tissue, does not rule out infection. Furthermore, the sensitivity and specificity of diagnostic tests vary according to the protocol of the test used (3). The geospatial overlap of dogs and vectors infected with L. infantum might be linked with human disease. For instance, in focal areas of Brazil the prevalence of infected dogs was associated with the occurrence of clinical VL cases (8,9). However, in areas to which Can-VL is endemic, attempts to control and prevent Can-VL using controversial procedures, including culling infected dogs, have failed to reduce the spread of human VL cases (6,7). In North America, most cases of leishmaniasis are acquired during travel or military service in areas to which the disease is endemic. However, leishmaniasis can also be transmitted within the United States. Sylvatic reservoir animals and sand flies, including Lutzomyia shannoni, L. longipalpis, L. anthophora, and L. diabolica, are endemic to many US states (2). Outbreaks and isolated cases of autochthonous Can-VL affecting foxhounds and other breeds have been reported over the past 2 decades in the United States and Canada (2,3,10). In addition, our laboratory identified a strain of Leishmania mexicana in Texas that infected >50 persons, including a patient who shared the same strain with an L. anthophora sand fly found in the household (11). Here we describe an autochthonous case of Can-VL caused by L. infantum sand flies in a US-born dog.

Case Report

In September 2016, a 1.3-year-old male neutered California-born boxer with no overseas travel history was brought to Sacramento Area Veterinary Internal Medicine (Sacramento, California, USA) by his owner. The dog had granulomatous cutaneous lesions, hypercalcemia, hyperphosphatemia, and hyperglobulinemia, a set of signs that prompted our diagnosis of systemic histiocytosis. The dog was from an apparently healthy litter born to an apparently healthy female relocated from Spain, a country to which Can-VL is endemic. We initially suspected lymphoma but ruled it out on the basis of splenic, lymph node, and bone marrow aspirates and a parathyroid-related peptide test that all yielded negative results. We treated the dog’s cutaneous lesions and biochemical abnormalities with a tapering dosage of oral prednisone. At the next appointment 17 months after the first visit, the dog had a mildly enlarged prescapular lymph node and anemia as well as biochemical abnormalities, including hyperglobulinemia and hypoalbuminemia. He had also lost ≈3.6 kg.

Figure

Thumbnail of Structures resembling Leishmania spp. amastigotes in a lymph node sample from a 1.3-year-old male boxer, California, USA. Sample was prepared in slides stained with Giemsa and examined by light microscopy. Molecular analysis identified the species as L. infantum. Original magnification ×1,000.

Figure. Structures resembling Leishmania spp. amastigotes in a lymph node sample from a 1.3-year-old male boxer, California, USA. Sample was prepared in slides stained with Giemsa and examined by light microscopy. Molecular...

In February 2018, we used light microscopy to identify structures consistent with Leishmania spp. amastigotes in an aspirate of the enlarged prescapular lymph node (Figure). We also performed a Leishmania indirect immunofluorescence assay serology evaluation with a serial 2-fold dilution of the dog serum. We determined positivity at dilutions of >1:64; the sample tested positive at a titer of 2,048. In March 2018, we confirmed infection with L. infantum using PCR followed by DNA sequencing analysis (GenBank accession no. MN991197) as previously described (12).

From March through July 2018, we treated the dog with 4 courses of marbofloxacin (100 mg orally every 24 hours) and allopurinol (265 mg orally every 12 hours). In August 2018, we briefly discontinued medications because of the development of neutropenia in the dog. From November 2018 through April 2019, we treated the dog with allopurinol (300 mg every 24 hours), and in April we increased the dose (to 300 mg every 12 hours). In May 2019, strabismus, anisocoria with progressive discomfort, and ataxia developed. A neurologist consult was declined by the dog’s owner, and we resumed marbofloxacin treatment. In mid-May we prescribed antiinflammatory therapy with prednisone as a palliative measure. However, these treatments did not alleviate signs, and we humanely euthanized the dog in late May. We were unable to locate siblings from the same litter for leishmaniasis testing. The breeder reported that the mother died in 2017 of an unknown cause.

Conclusions

We diagnosed Can-VL in a US-born dog. Given the lack of other risk factors for Can-VL infection, we hypothesize that the dog probably acquired infection through vertical transmission. In countries to which Can-VL is endemic, veterinarians most likely would consider leishmaniasis as a potential diagnosis for fever, granulomatous skin lesions, and weight loss in a dog. However, in the United States, veterinarians often consider leishmaniasis to be a travel-acquired disease and might not suspect this infection in a dog with similar signs. Therefore, veterinarians should consider Can-VL as a potential diagnosis, depending on the dog’s travel and breeding history. Dogs infected with Leishmania spp. are important reservoirs, especially in areas where competent vector sand flies are found. Dogs with Can-VL, clinical or subclinical, might contribute to parasite transmission and the occurrence of VL in humans (79,13). In areas where sand fly vectors are not prevalent, infectious dogs relocated or returning from areas to which the disease is endemic can still spread Can-VL through transmission routes such as biting, blood transfusion, and breeding (10). Current measures to control Can-VL include the regular use of topical sand fly repellents, canine vaccination, and treatment of infected dogs (6,7).

Changing environmental factors may expand the geographic range of sand fly vectors in North America (14), increasing the exposure of humans and animals to the disease. The existence of competent vectors for Leishmania spp. in the United States has been demonstrated through a growing number of recently reported autochthonous human cases. For example, >50 human autochthonous cases of cutaneous leishmaniasis caused by L. mexicana have been reported in Texas and Oklahoma (11,14). Meanwhile, a possible autochthonous infection with an Leishmania donovani complex species in a 2-year-old boy was recently reported in North Dakota (15).

We hypothesize that this case of Can-VL was probably acquired through vertical transmission because of the lack of evidence supporting California as a leishmaniasis endemic region and the fact that this dog, who had no travel history, was born to a female dog relocated from Spain. Given the lack of surveillance and relative ease of dog-to-dog transmission, Can-VL is probably underreported in North America. The veterinary and public health community should be alert to the existence of autochthonous canine infections and competent vectors of Leishmania parasites in the United States, which might contribute to the occurrence of VL in humans. The risk for vertical transmission of Can-VL highlights the need to test all animals either relocated or retuning from areas to which the disease is endemic. This testing will be crucial to improving the surveillance and control of leishmaniasis in North America.

Dr. de Almeida is an associate service fellow in the Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Diseases Control and Prevention, Atlanta. His primary research interests include the development of molecular diagnostic tests for parasites.

Top

Acknowledgment

We thank Jacqueline Brady and Henry Bishop for the invaluable assistance on creating the tissue smears and image preparation.

Top

References

  1. Alvar  J, Vélez  ID, Bern  C, Herrero  M, Desjeux  P, Cano  J, et al.; WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671. DOIPubMed
  2. Duprey  ZH, Steurer  FJ, Rooney  JA, Kirchhoff  LV, Jackson  JE, Rowton  ED, et al. Canine visceral leishmaniasis, United States and Canada, 2000-2003. Emerg Infect Dis. 2006;12:4406. DOIPubMed
  3. Petersen  CA, Barr  SC. Canine leishmaniasis in North America: emerging or newly recognized? [vi.] [vi.]. Vet Clin North Am Small Anim Pract. 2009;39:106574, vi. DOIPubMed
  4. Boggiatto  PM, Gibson-Corley  KN, Metz  K, Gallup  JM, Hostetter  JM, Mullin  K, et al. Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. PLoS Negl Trop Dis. 2011;5:e1019. DOIPubMed
  5. Sanchez-Robert  E, Altet  L, Utzet-Sadurni  M, Giger  U, Sanchez  A, Francino  O. Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis. Vet Res. 2008;39:36. DOIPubMed
  6. Dantas-Torres  F, Miró  G, Baneth  G, Bourdeau  P, Breitschwerdt  E, Capelli  G, et al. Canine leishmaniasis control in the context of One Health. Emerg Infect Dis. 2019;25:14. DOIPubMed
  7. Otranto  D, Dantas-Torres  F. The prevention of canine leishmaniasis and its impact on public health. Trends Parasitol. 2013;29:33945. DOIPubMed
  8. Teixeira-Neto  RG, da Silva  ES, Nascimento  RA, Belo  VS, de Oliveira  C, Pinheiro  LC, et al. Canine visceral leishmaniasis in an urban setting of Southeastern Brazil: an ecological study involving spatial analysis. Parasit Vectors. 2014;7:485. DOIPubMed
  9. Ursine  RL, Dias  JV, Morais  HA, Pires  HH. Human and canine visceral leishmaniasis in an emerging focus in Araçuaí, Minas Gerais: spatial distribution and socio-environmental factors. Mem Inst Oswaldo Cruz. 2016;111:50511. DOIPubMed
  10. Schaut  RG, Robles-Murguia  M, Juelsgaard  R, Esch  KJ, Bartholomay  LC, Ramalho-Ortigao  M, et al. Vectorborne transmission of Leishmania infantum from hounds, United States. Emerg Infect Dis. 2015;21:220912. DOIPubMed
  11. Kipp  EJ, de Almeida  M, Marcet  PL, Bradbury  RS, Benedict  T, Lin  W, et al. An atypical case of autochthonous cutaneous leishmaniasis associated with naturally infected phlebotomine sand flies in Texas, United States. Am J Trop Med Hyg. 2020. In press. DOIPubMed
  12. de Almeida  ME, Steurer  FJ, Koru  O, Herwaldt  BL, Pieniazek  NJ, da Silva  AJ. Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2. J Clin Microbiol. 2011;49:31439. DOIPubMed
  13. Courtenay  O, Carson  C, Calvo-Bado  L, Garcez  LM, Quinnell  RJ. Heterogeneities in Leishmania infantum infection: using skin parasite burdens to identify highly infectious dogs. PLoS Negl Trop Dis. 2014;8:e2583. DOIPubMed
  14. McIlwee  BE, Weis  SE, Hosler  GA. Incidence of endemic human cutaneous leishmaniasis in the United States. JAMA Dermatol. 2018;154:10329. DOIPubMed
  15. Douvoyiannis  M, Khromachou  T, Byers  N, Hargreaves  J, Murray  HW. Cutaneous leishmaniasis in North Dakota. Clin Infect Dis. 2014;59:e735. DOIPubMed

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2608.200149

Original Publication Date: July 14, 2020

Table of Contents – Volume 26, Number 8—August 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Marcos de Almeida, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H23-9, Atlanta, GA 30329-4027, USA

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: May 20, 2020
Page updated: July 19, 2020
Page reviewed: July 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external